Use my Search Websuite to scan PubMed, PMCentral, Journal Hosts and Journal Archives, FullText. Kick-your-searchterm to multiple Engines kick-your-query now !>

A dictionary by aggregated review articles of nephrology, medicine and the life sciences Your one-stop-run pathway from word to the immediate pdf of peer-reviewed on-topic knowledge.

10.1016/j.cmi.2021.06.009 http://scihub22266oqcxt.onion/10.1016/j.cmi.2021.06.009 34139334!8200326!34139334     free     free     free Warning: file_get_contents(https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&id=34139334&cmd=llinks): Failed to open stream: HTTP request failed! HTTP/1.1 429 Too Many Requests in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 215       Clin+Microbiol+Infect 2022 ; 28 (2): 292-296 Nephropedia Template TP {{tp|p=34139334|t=2022. Longevity of seropositivity and neutralizing antibodies in recovered MERS patients: a 5-year follow-up study |pdf=|usr=}}{{34139334}} gab.com Text Longevity of seropositivity and neutralizing antibodies in recovered MERS patients: a 5-year follow-up study JO: Clin Microbiol Infect http://www.kidney.de/pget.php?&tw=1&pmid=34139334 #FOAvip OBJECTIVES: We aimed to assess the longevity of spike-specific antibody responses and neutralizing activity in the plasma of recovered Middle East respiratory syndrome (MERS) patients. METHODS: We traced the antibody responses and neutralizing activity against MERS coronavirus (MERS-CoV) in peripheral blood samples collected from 70 recovered MERS patients for 5 years after the 2015 MERS outbreak in South Korea. We also measured the half-life of neutralizing antibody titres in the longitudinal specimens. RESULTS: The seropositivity rate persisted for up to 4 years (50.7-56.1%), especially in MERS patients who suffered from severe pneumonia, and then decreased (35.9%) in the fifth year. Although the spike-specific antibody responses decreased gradually, the neutralizing antibody titres decreased more rapidly (half-life: 20 months) in 19 participants without showing negative seroconversion during the study period. Only five (26.3%) participants had neutralizing antibody titres greater than 1/1000 of PRNT(50), and a high neutralizing antibody titre over 1/5000 was not detected in the participants at five years after infection. DISCUSSION: The seropositivity rate of the recovered MERS patients persisted up to 4 years after infection and significantly dropped in the fifth year, whereas the neutralizing antibody titres against MERS-CoV decreased more rapidly and were significantly reduced at 4 years after infection. Twit Text FOAVip Longevity of seropositivity and neutralizing antibodies in recovered MERS patients: a 5-year follow-up study ????Clin Microbiol Infect http://www.kidney.de/pget.php?&tw=1&pmid=34139334 #FOAvip Twit Text # Free Paper on # # # # # LINK http://www.kidney.de/pget.php?&tw=1&pmid=34139334 #FOAvip English Wikipedia <ref>{{Cite pmid|34139334}}</ref> Longevity of seropositivity and neutralizing antibodies in recovered MERS patients: a 5-year follow-up study #MMPMID34139334 Cheon S; Park U; Park H; Kim Y; Nguyen YTH; Aigerim A; Rhee JY; Choi JP; Park WB; Park SW; Kim Y; Lim DG; Yang JS; Lee JY; Kim YS; Cho NH Clin Microbiol Infect 2022[Feb]; 28 (2): 292-296 PMID34139334show ga OBJECTIVES: We aimed to assess the longevity of spike-specific antibody responses and neutralizing activity in the plasma of recovered Middle East respiratory syndrome (MERS) patients. METHODS: We traced the antibody responses and neutralizing activity against MERS coronavirus (MERS-CoV) in peripheral blood samples collected from 70 recovered MERS patients for 5 years after the 2015 MERS outbreak in South Korea. We also measured the half-life of neutralizing antibody titres in the longitudinal specimens. RESULTS: The seropositivity rate persisted for up to 4 years (50.7-56.1%), especially in MERS patients who suffered from severe pneumonia, and then decreased (35.9%) in the fifth year. Although the spike-specific antibody responses decreased gradually, the neutralizing antibody titres decreased more rapidly (half-life: 20 months) in 19 participants without showing negative seroconversion during the study period. Only five (26.3%) participants had neutralizing antibody titres greater than 1/1000 of PRNT(50), and a high neutralizing antibody titre over 1/5000 was not detected in the participants at five years after infection. DISCUSSION: The seropositivity rate of the recovered MERS patients persisted up to 4 years after infection and significantly dropped in the fifth year, whereas the neutralizing antibody titres against MERS-CoV decreased more rapidly and were significantly reduced at 4 years after infection. |*Coronavirus Infections/epidemiology[MESH] |*Middle East Respiratory Syndrome Coronavirus[MESH] |Antibodies, Neutralizing[MESH] |Antibodies, Viral[MESH] |Follow-Up Studies[MESH] |Humans[MESH]Longevity of seropositivity and neutralizing antibodies in recovered M(epmc).pdf DeepDyve Pubget Overpricing